Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01754779 · ClinicalTrials.gov registry record · Phase 2
Treatment for Calcium Phosphate Kidney Stone Disease
A Phase 2 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 13
- Enrollment target
NCT01754779 is a Phase 2 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 13 participants.
The verdict
NCT01754779, a Phase 2 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 13 participants
- Enrollment target
Study Summary
The investigators will examine in two studies whether citric acid or potassium citrate can reduce calcium phosphate saturation in urine of Calcium Phosphate stone formers.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Citric Acid
- DIETARY_SUPPLEMENT Potassium Citrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2012-07 |
| Est. Completion | 2023-02-16 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01754779
The ClinicalTrials.gov registry entry for NCT01754779 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01754779 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01754779 about?
NCT01754779 is a clinical study titled "Treatment for Calcium Phosphate Kidney Stone Disease". The investigators will examine in two studies whether citric acid or potassium citrate can reduce calcium phosphate saturation in urine of Calcium Phosphate stone formers.
What is the current status of trial NCT01754779?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 13 participants. The study started on 2012-07. Estimated completion is 2023-02-16.
What interventions are being tested in trial NCT01754779?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Citric Acid (DIETARY_SUPPLEMENT), Potassium Citrate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01754779?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.